High expression of LIAS was associated with good prognosis in patients with ccRCC, READ, BRCA, and OC, whereas high expression of LIAS was associated with poor prognosis in lung cancer patients. This evidence concerns the gene LIAS and nonpapillary renal cell carcinoma.